Following the successful float of Virtus Health last year, Monash IVF Group is currently one of the IPO's being marketed to Australian investors

Livewire Exclusive

Livewire Markets

Following the successful float of Virtus Health last year, Monash IVF Group is currently one of the IPO's being marketed to Australian investors. David Allingham analyst at small company specialist Eley Griffiths Group says it is one worth keeping an eye on. Monash IVF Group is an IPO we are working on and operates in the field of fertility services in Australia and Malaysia. At a 15% discount to Virtus Health (VRT) we think the stock is priced appropriately. Monash is a Victorian centric business and has plans to grow a larger presence in NSW, QLD and Malaysia. Forecast EPS growth of 18% in the 2015 looks achievable and will be supported by a more affordable low intervention IVF offering which VRT has pioneered.


Livewire Exclusive brings you exclusive content from a wide range of leading fund managers and investment professionals.

I would like to

Only to be used for sending genuine email enquiries to the Contributor. Livewire Markets Pty Ltd reserves its right to take any legal or other appropriate action in relation to misuse of this service.

Personal Information Collection Statement
Your personal information will be passed to the Contributor and/or its authorised service provider to assist the Contributor to contact you about your investment enquiry. They are required not to use your information for any other purpose. Our privacy policy explains how we store personal information and how you may access, correct or complain about the handling of personal information.